Test Code: CER
EGFR Cancer-Related Gene Screening, 3 Mutations (Plasma)
This test is for the detection of exon 19 deletions, exon 20 and 21 substitutions (T790M and L858R respectively) in the epidermal growth factor receptor (EGFR) gene and will provide a qualitative assessment of the mutation status. Results are intended to aid the clinician in identifying patients with NSCLC who may benefit from treatment with IRESSA (gefitinib), when a tissue sample cannot be evaluated.
10ml EDTA Blood
Turnaround Time :
Maximum to 5 days